Kezdeti tapasztalatok a Sorin Perceval S aorta biológiai billentyű beültetésével

Translated title of the contribution: Early experiences with the Sorin Perceval S arteficial biological valve

László Csepregi, Gábor Bari, Miklós Bitay, Zoltán Hegedűs, Sándor Varga, Gábor Iglói, Antal Szabó-B, István Hartyánszky, G. Bogáts

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: We examined the Sorin Perceval S artificial biological valve implantation techniques, and present the initial experiences in our unit.

METHODS: In the last 1.5 years, 27 patients had been implanted with Sorin Perceval S biological arteficial valve due to aortic valve disease. The device was mainly used in high-risk patients, in reoperative circumstances, in cases of calcified aortic root, and in elderly patients.

RESULTS: The valve implantation time, aortic cross clamp time is shorter, but the risk of the operation cannot be eliminated entirely, because of the high risk patients' severe comorbidities. Furthermore, we performed echocardiography in the postoperative period, which demonstrated that the valve function is excellent, the valve fitted tightly in the anulus, and there was no paravalvular leakage.

CONCLUSIONS: The Sorin Perceval S biological arteficial aortic valve is safe to use in high risk patients, and the surgical procedure is easier in case of partial sternotomy, too.

Original languageHungarian
Pages (from-to)54-57
Number of pages4
JournalMagyar sebészet
Volume69
Issue number2
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Aortic Valve
Aortic Diseases
Sternotomy
Postoperative Period
Echocardiography
Comorbidity
Equipment and Supplies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kezdeti tapasztalatok a Sorin Perceval S aorta biológiai billentyű beültetésével. / Csepregi, László; Bari, Gábor; Bitay, Miklós; Hegedűs, Zoltán; Varga, Sándor; Iglói, Gábor; Szabó-B, Antal; Hartyánszky, István; Bogáts, G.

In: Magyar sebészet, Vol. 69, No. 2, 01.06.2016, p. 54-57.

Research output: Contribution to journalArticle

Csepregi, L, Bari, G, Bitay, M, Hegedűs, Z, Varga, S, Iglói, G, Szabó-B, A, Hartyánszky, I & Bogáts, G 2016, 'Kezdeti tapasztalatok a Sorin Perceval S aorta biológiai billentyű beültetésével', Magyar sebészet, vol. 69, no. 2, pp. 54-57. https://doi.org/10.1556/1046.69.2016.2.2
Csepregi L, Bari G, Bitay M, Hegedűs Z, Varga S, Iglói G et al. Kezdeti tapasztalatok a Sorin Perceval S aorta biológiai billentyű beültetésével. Magyar sebészet. 2016 Jun 1;69(2):54-57. https://doi.org/10.1556/1046.69.2016.2.2
Csepregi, László ; Bari, Gábor ; Bitay, Miklós ; Hegedűs, Zoltán ; Varga, Sándor ; Iglói, Gábor ; Szabó-B, Antal ; Hartyánszky, István ; Bogáts, G. / Kezdeti tapasztalatok a Sorin Perceval S aorta biológiai billentyű beültetésével. In: Magyar sebészet. 2016 ; Vol. 69, No. 2. pp. 54-57.
@article{3cdf099d3e394e5fb306c6a7bcbbe960,
title = "Kezdeti tapasztalatok a Sorin Perceval S aorta biol{\'o}giai billentyű be{\"u}ltet{\'e}s{\'e}vel",
abstract = "OBJECTIVES: We examined the Sorin Perceval S artificial biological valve implantation techniques, and present the initial experiences in our unit.METHODS: In the last 1.5 years, 27 patients had been implanted with Sorin Perceval S biological arteficial valve due to aortic valve disease. The device was mainly used in high-risk patients, in reoperative circumstances, in cases of calcified aortic root, and in elderly patients.RESULTS: The valve implantation time, aortic cross clamp time is shorter, but the risk of the operation cannot be eliminated entirely, because of the high risk patients' severe comorbidities. Furthermore, we performed echocardiography in the postoperative period, which demonstrated that the valve function is excellent, the valve fitted tightly in the anulus, and there was no paravalvular leakage.CONCLUSIONS: The Sorin Perceval S biological arteficial aortic valve is safe to use in high risk patients, and the surgical procedure is easier in case of partial sternotomy, too.",
keywords = "aortabillentyű-be{\"u}ltet{\'e}s, aortic valve implantation, parci{\'a}lis sternotomia, partial sternotomy, Sorin Perceval S, TAVI (transcatheter aortic valve implantation), TAVI – Transcatheter Aortic Valve Implantation",
author = "L{\'a}szl{\'o} Csepregi and G{\'a}bor Bari and Mikl{\'o}s Bitay and Zolt{\'a}n Hegedűs and S{\'a}ndor Varga and G{\'a}bor Igl{\'o}i and Antal Szab{\'o}-B and Istv{\'a}n Harty{\'a}nszky and G. Bog{\'a}ts",
year = "2016",
month = "6",
day = "1",
doi = "10.1556/1046.69.2016.2.2",
language = "Hungarian",
volume = "69",
pages = "54--57",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "2",

}

TY - JOUR

T1 - Kezdeti tapasztalatok a Sorin Perceval S aorta biológiai billentyű beültetésével

AU - Csepregi, László

AU - Bari, Gábor

AU - Bitay, Miklós

AU - Hegedűs, Zoltán

AU - Varga, Sándor

AU - Iglói, Gábor

AU - Szabó-B, Antal

AU - Hartyánszky, István

AU - Bogáts, G.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - OBJECTIVES: We examined the Sorin Perceval S artificial biological valve implantation techniques, and present the initial experiences in our unit.METHODS: In the last 1.5 years, 27 patients had been implanted with Sorin Perceval S biological arteficial valve due to aortic valve disease. The device was mainly used in high-risk patients, in reoperative circumstances, in cases of calcified aortic root, and in elderly patients.RESULTS: The valve implantation time, aortic cross clamp time is shorter, but the risk of the operation cannot be eliminated entirely, because of the high risk patients' severe comorbidities. Furthermore, we performed echocardiography in the postoperative period, which demonstrated that the valve function is excellent, the valve fitted tightly in the anulus, and there was no paravalvular leakage.CONCLUSIONS: The Sorin Perceval S biological arteficial aortic valve is safe to use in high risk patients, and the surgical procedure is easier in case of partial sternotomy, too.

AB - OBJECTIVES: We examined the Sorin Perceval S artificial biological valve implantation techniques, and present the initial experiences in our unit.METHODS: In the last 1.5 years, 27 patients had been implanted with Sorin Perceval S biological arteficial valve due to aortic valve disease. The device was mainly used in high-risk patients, in reoperative circumstances, in cases of calcified aortic root, and in elderly patients.RESULTS: The valve implantation time, aortic cross clamp time is shorter, but the risk of the operation cannot be eliminated entirely, because of the high risk patients' severe comorbidities. Furthermore, we performed echocardiography in the postoperative period, which demonstrated that the valve function is excellent, the valve fitted tightly in the anulus, and there was no paravalvular leakage.CONCLUSIONS: The Sorin Perceval S biological arteficial aortic valve is safe to use in high risk patients, and the surgical procedure is easier in case of partial sternotomy, too.

KW - aortabillentyű-beültetés

KW - aortic valve implantation

KW - parciális sternotomia

KW - partial sternotomy

KW - Sorin Perceval S

KW - TAVI (transcatheter aortic valve implantation)

KW - TAVI – Transcatheter Aortic Valve Implantation

UR - http://www.scopus.com/inward/record.url?scp=84987680698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987680698&partnerID=8YFLogxK

U2 - 10.1556/1046.69.2016.2.2

DO - 10.1556/1046.69.2016.2.2

M3 - Article

C2 - 27328925

AN - SCOPUS:84987680698

VL - 69

SP - 54

EP - 57

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 2

ER -